|
1
|
Pereira MC, Oliveira DT, Landman G and
Kowalski LP: Histologic subtypes of oral squamous cell carcinoma:
prognostic relevance. J Can Dent Assoc. 73:339–344. 2007.PubMed/NCBI
|
|
2
|
Sudbo J, Bryne M, Mao L, Lotan R, et al:
Molecular based treatment of oral cancer. Oral Oncol. 39:749–758.
2003. View Article : Google Scholar
|
|
3
|
Leemans CR, Tiwari R, Nauta JJ, van der
Waal I and Snow GB: Regional lymph node involvement and
significance in the development of distant metastases in head and
neck carcinoma. Cancer. 71:452–456. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leemans CR, Tiwari R, Nauta JJ, van der
Waal I and Snow GB: Recurrence at the primary site in head and neck
cancer and the significance of neck lymph node metastases as a
prognostic factor. Cancer. 73:187–190. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brattain MG, Willson J, Koterba A, Patil S
and Venkateswarlu S: Colorectal cancer. Human Cell Culture. Cancer
Cell Lines, Part 2. Masters JR and Palsson B: 2. Kluwer Academic
Publishers; Norwell, MA: pp. 293–304. 2002
|
|
6
|
Kozlowski J and Sensibar JA: Prostate
cancer. Human Cell Culture. Cancer Cell Lines, Part 2. Masters JR
and Palsson B: 2. Kluwer Academic Publishers; Norwell, MA: pp.
305–332. 2002
|
|
7
|
Sutherland R, Watts CK, Lee CS and
Musgrove EA: Breast cancer. Human Cell Culture. Cancer Cell Lines,
Part 2. Masters JR and Palsson B: 2. Kluwer Academic Publishers;
Norwell, MA: pp. 79–106. 2002
|
|
8
|
Yokoyama K, Kamata N, Hayashi E, Hoteiya
T, Ueda N, Fujimoto R and Nagayama M: Reverse correlation of
E-cadherin and snail expression in oral squamous cell carcinoma
cells in vitro. Oral Oncol. 37:65–71. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frixen UH, Behrens J, Sachs M, et al:
E-cadherin-mediated cell-cell adhesion prevents invasiveness of
human carcinoma cells. J Cell Biol. 113:173–185. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Petit MM, Fradelizi J, Golsteyn RM, et al:
LPP, an actin cytoskeleton protein related to zyxin, harbors a
nuclear export signal and transcriptional activation capacity. Mol
Biol Cell. 11:117–129. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yi J and Beckerle MC: The human TRIP6 gene
encodes a LIM domain protein and maps to chromosome 7q22, a region
associated with tumorigenesis. Genomics. 49:314–316. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grunewald TG, Kammerer U, Schulze E,
Schindler D, Hong A, Zimmer M and Butt E: Silencing of LASP-1
influences zyxin localization, inhibits proliferation and reduces
migration in breast cancer cells. Exp Cell Res. 312:974–982. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grunewald TG, Kammerer U, Winkler C,
Schindler D, Sickmann A, Honig A and Butt E: Overexpression of
LASP-1 mediates migration and proliferation of human ovarian cancer
cells and influences zyxin localisation. Br J Cancer. 96:296–305.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hervy M, Hoffman L and Beckerle MC: From
the membrane to the nucleus and back again: bifunctional focal
adhesion proteins. Curr Opin Cell Biol. 18:524–532. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nix DA and Beckerle MC:
Nuclear-cytoplasmic shuttling of the focal contact protein, zyxin:
a potential mechanism for communication between sites of cell
adhesion and the nucleus. J Cell Biol. 138:1139–1147. 1997.
View Article : Google Scholar
|
|
16
|
Nix DA, Fradelizi J, Bockholt S, Menichi
B, Louvard D, Friedich E and Beckerle MC: Targeting of zyxin to
sites of actin membrane interaction and to the nucleus. J Biol
Chem. 276:34759–34767. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van der Gaag EJ, Leccica MT, Dekker SK,
Jalbert NL, Amodeo DM and Byers HR: Role of Zyxin in differential
cell spreading and proliferation of melanoma cells and melanocytes.
J Invest Dermatol. 118:246–254. 2002.PubMed/NCBI
|
|
18
|
Sperry RB, Bishop SN, Bramwell JJ, et al:
Zyxin controls migration in epithelial-mesenchymal transition by
mediating actin-membrane linkages at cell-cell junctions. J Cell
Physiol. 222:612–624. 2010.PubMed/NCBI
|
|
19
|
Urade M, Sugi M and Miyazaki T:
Establishment of three bleomycin-resistant human carcinoma cell
lines and their cross resistance to other antitumor agents. Cancer.
61:1501–1507. 1998. View Article : Google Scholar
|
|
20
|
Kamata N, Chida K, Rikimaru K, Horikoshi
M, Enomoto S and Kuroki T: Growth inhibitory effects of epidermal
growth factor and overexpression of its receptors on human squamous
cell carcinomas in culture. Cancer Res. 46:1648–1653.
1986.PubMed/NCBI
|
|
21
|
Kawahara E, Okada Y, Nakanishi I, Iwata K,
Kojima S, Kumagai S and Yamamoto E: The expression of invasive
behavior of differentiated squamous carcinoma cell line evaluated
by an in vitro invasion model. Jpn J Cancer Res. 84:409–418. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kojima S: Experimenral study of invasive
activity of oral squamous cell carcinoma. J Juzen Med Soc.
101:266–281. 1992.
|
|
23
|
Hoteiya T, Hayashi E, Satomura K, Kamata N
and Nagayama N: Expression of E-cadherin in oral cancer cell lines
and its relationship to invasiveness in SCID mice in vivo. J Oral
Pathol Med. 28:107–111. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kawashiri S, Tanaka A, Noguchi N, et al:
Invasion and metastasis models of oral squamous carcinoma cell
lines. Jpn J Tissue Cult Dent Res. 12:1–13. 2004.(in Japanese).
|
|
25
|
Moriyama M: Development of diffuse
invasive (grade4D) human oral squamous cell carcinoma model in
severe combined immunodeficiency mice: microangioarchitectual
analysis and immunohistochemical study. Oral Oncol. 35:395–400.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hashitani S, Urade M, Nishimura N, Maeda
N, Takaoka K, Noguchi K and Sakurai K: Apoptosis induction
enhancement of anticancer drugs by celecoxib, a selective
cyclooxygenase-2 inhibitor, in human head neck carcinoma cell
lines. Int J Oncol. 23:665–672. 2003.
|
|
27
|
Hiromoto T, Noguchi K, Yamamura M, et al:
Up-regulation of neurophil gelatinase-associated lipocalin in oral
squaamous cell carcinoma: relation to cell differentiation. Oncol
Rep. 26:1415–1421. 2011.PubMed/NCBI
|
|
28
|
Higashikawa K, Yoneda S, Tobiume K, et al:
ΔNp63α-dependent expression of Id-3 distinctively suppresses the
invasiveness of human squamous cell carcinoma. Int J Cancer.
124:2837–2844. 2009.
|
|
29
|
Bendris N, Arsic N, Lemmers B and
Bianchard JM: Cyclin A2, Rho GTPases and EMT. Small GTPases. Oct
1–2012.(Epub ahead of print).
|
|
30
|
Diniz-Freitas M, García-Caballero T,
Antúnez-López J, Gándara-Rey JM and García-García A: Reduced
E-cadherin expression is an indicator of unfavourable prognosis in
oral squamous cell carcinoma. Oral Oncol. 42:190–200. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tanaka N, Odajima T, Ogi K, Ikeda T and
Satoh M: Expression of E-cadherin, alpha-catenin, and beta-catenin
in the process of lymph node metastasis in oral squamous cell
carcinoma. Br J Cancer. 89:557–563. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Krisanaprakornkit S and Iamaroon A:
Epithelial-mesenchymal transition in oral squamous cell carcinoma.
ISRN Oncol. 681469. 2012. View Article : Google Scholar
|
|
33
|
Fradelizi j, Noireaux V, Plastino J, et
al: ActA and human zyxin harbor Arp2/3-independent
actin-polymerization activity. Nat Cell Biol. 3:699–707. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Beckerle MC: Spatial control of action
filament assembly: lessons from Listeria. Cell. 95:741–748. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kadrmas JL and Beckerle MC: The LIM
domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell
Biol. 5:920–931. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reiling JH and Sabatini DM: Stress and
mTORture signaling. Oncogene. 25:6373–6383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shinto O, Yashiro M, Kawajiri H, Shimizu
K, Shimizu T, Miwa A and Hirakawa K: Inhibitory effect of a TGFbeta
receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous
gastric cancer cells. Br J Cancer. 102:844–851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Amsellem V, Kryszke MH, Hervy M, et al:
The actin cytoskeleton-associated protein zyxin acts as a tumor
suppressor in Ewing tumor cells. Exp Cell Res. 304:443–456. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wendt MK, Allington TM and Schiemann WP:
Mechanisms of the epithelial-mesenchymal transition by TGF-beta.
Future Oncol. 5:1145–1168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pratt S J, Epple H, Ward M, Feng Y, Braga
VM and Longmore GD: The LIM protein Ajuba influences p130Cas
localization and Rac1 activity during cell migration. J Cell Biol.
168:813–824. 2005.PubMed/NCBI
|
